Workflow
PDS Biotechnology(PDSB) - 2021 Q2 - Earnings Call Presentation

CORPORATE OVERVIEW AUGUST 2021 Frank Bedu-Addo Ph.D. President & CEO 6 Nasdaq: PDSB Developing powerful, safe, versatile immunotherapies Forward-Looking Statements | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...